Under-diagnosis of diabetes mellitus in patients with coronary artery disease
- 1 October 2004
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 97 (1) , 77-82
- https://doi.org/10.1016/j.ijcard.2003.08.012
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cardioprotective Effect of Prior β-Blocker Therapy in Reducing Creatine Kinase-MB Elevation After Coronary InterventionCirculation, 2000
- Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trialBMJ, 2000
- beta Blockade after myocardial infarction: systematic review and meta regression analysisBMJ, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- The β-Blocker Heart Attack TrialPublished by American Medical Association (AMA) ,1981